Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class I · High risk Terminated Initiated Jan 9, 2016 (11 years ago)

Bigger Longer More Time More Sperms

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Marketed Without An Approved NDA/ANDA

Cause type: Unapproved drug

The product was marketed without an approved NDA/ANDA, or does not meet the OTC monograph it claims to follow. Nothing about the product - dose, purity, safety - has been reviewed by FDA, so the claims on the box are unverified. All unapproved drug recalls.

What was recalled

Bigger Longer More Time More Sperms, packaged in BIG BOX (6 small boxes / 6 capsules per small box / 36 capsules), Distributed by: R Thomas Marketing, LLC, Bronx, NY 10467

Recalling firm
R Thomas Marketing, LLC
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0894-2016 · FDA notice

Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by R Thomas Marketing, LLC

All 2016 recalls
Class I · High risk

Zhen Gong Fu

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0907-2016
Class I · High risk

Super Hard

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0906-2016
Class I · High risk

Samurai-X

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0905-2016
Class I · High risk

Tiger King

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0904-2016

Other unapproved drug recalls from 2016

All unapproved drug recalls
Class I · High risk

Domperidone capsules 10 mg

Marketed without an approved NDA/ANDA for which safety and efficacy has not been established.

Terminated Unapproved drug Jeffreys Drug Store D-0494-2017
Class II · Moderate risk

Zinc Acetate

Does not meet monograph: product exhibits lead levels in excess of the USP monograph limits.

Terminated Unapproved drug Spectrum Laboratory Products, Inc. D-1456-2016
Class II · Moderate risk

Oxygen Nasal Wash

Marketed Without An Approved NDA/ANDA: product is an unapproved drug due to nasal decongestant claims as well as not complying with the nasal decongestant final monograph.

Terminated Unapproved drug Let's Talk Health, Inc. D-1452-2016
Class II · Moderate risk

Fuqingsong Relief Cream

Marketed Without An Approved NDA/ANDA: Products marked as dietary supplements have labeling that bears drug/disease claims, making them unapproved drugs.

Terminated Unapproved drug Murray International Trading Co., Inc. D-1358-2016